In our previous study, we found that PSMA and CD248 were both expressed specifically in the vasculature in hepatocellular carcinoma (HCC), and vascular-expressed PSMA and CD248 might be used as prognostic markers and vascular therapeutic targets for HCC (30, 31). Here, FOLH1 is linked to hepatocellular carcinoma.